【Native Speaker每日综合训练—38系列】【38-07】科技 Stem Cells

SukeyZhou

20160621
【38-07】科技 Stem Cells
【Time 2】
It’s hard for venture capitalists to invest in stem cells, because the science is too preliminary and the business plans are too risky.

【Time 3】
The author talks about how various companies around the world have a trial to invest in stem cells. And only a few companies survives.

【Time 4】
It’s about a trial to bridge the gap between academic study and clinical trials.

【Time 5】
Here is another obstacle: regulatory side of different countries, which makes a cell stem therapy a fragmented marketplace.

【Time 6】
Since there are many obstacles for the business of cell stems, the businesses have to be more sophisticated towards risk. And the author believes that this kind of business is investible.

【Paraphrase 7】
The author talks about the regulation on the experiments and research of cell stems.


Time 2  00:03:09
Time 3  00:03:30
Time 4  00:01:26
Time 5  00:01:22
Time 6  00:00:53
Paraphrase 7  00:05:15